Home › Encyclopedia › Beinaglutide: Research Status, Identity, and Trial Data
Research / Unapproved

Beinaglutide: Research Status, Identity, and Trial Data

Molecular formulaC149H225N39O46
Molecular weight3298.6 g/mol
Registered trials3
PubChem CID16209124

What Beinaglutide Is

Beinaglutide is a synthetic peptide compound with the molecular formula C149H225N39O46 and a molecular weight of approximately 3298.6 daltons (PubChem CID 16209124). No FDA-approved label exists for this compound, and it is not registered under an RxNorm identifier in the data reviewed. It should be understood as a research and investigational substance rather than an approved medicine.

Trial Footprint

Three trials referencing beinaglutide are registered. The available sample includes a recruiting study comparing continuous subcutaneous beinaglutide delivery against insulin pump therapy (CSII) in newly diagnosed type 2 diabetes patients (NCT03987308). A completed trial examined beinaglutide against glargine therapy for glycemic variability in type 2 diabetes (NCT03829891). A third trial, with unknown status, compared beinaglutide and dulaglutide for glucose control and weight loss in overweight or obese individuals with type 2 diabetes (NCT05005741).

FAQ

Is beinaglutide FDA approved?
No. Beinaglutide does not have an FDA-approved label based on the data reviewed. It remains classified as an unapproved research compound in this context.
What is beinaglutide made of?
Beinaglutide is a peptide with the molecular formula C149H225N39O46 and a molecular weight of about 3298.6 daltons. It is identified in PubChem under CID 16209124.
How many clinical trials involve beinaglutide?
There are three registered clinical trials referencing beinaglutide. These include studies in type 2 diabetes comparing beinaglutide to insulin pump therapy, glargine, and dulaglutide.
What conditions are being studied with beinaglutide?
The available trials focus on type 2 diabetes, examining glycemic control, glycemic variability, and weight outcomes. None of these trials confirm approved uses or efficacy.
Are the beinaglutide trials completed?
The trial status varies. One sampled trial is completed, one is recruiting, and one has an unknown status, according to the data reviewed.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov

Updated 2026-09-19